These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16724168)

  • 1. Val/Leu247 and Trp/Ser316 polymorphisms in beta 2 glycoprotein I and their association with thrombosis in unselected Chilean patients.
    Palomo I; Pereira J; Alarcón M; Vásquez M; Pinochet C; Poblete F; Mendez E; Sandoval J; Vidal R; Pierangeli S
    Clin Rheumatol; 2007 Mar; 26(3):302-7. PubMed ID: 16724168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis.
    Palomo I; Pereira J; Alarcón M; Vásquez M; Pinochet C; Vélez MT; Sandoval J; Icaza G; Pierangeli S
    Clin Rheumatol; 2004 Apr; 23(2):129-33. PubMed ID: 15045627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Val/Leu247 polymorphism of beta2-glycoprotein I in Brazilian patients with antiphospholipid syndrome--a genetic risk factor?
    Pernambuco-Climaco JM; Brochado MJ; Freitas MV; Roselino AM; Louzada-Junior P
    Ann N Y Acad Sci; 2009 Sep; 1173():509-14. PubMed ID: 19758193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the valine/leucine247 polymorphism of β2-glycoprotein I and susceptibility to anti-phospholipid syndrome: a meta-analysis.
    Lee YH; Choi SJ; Ji JD; Song GG
    Lupus; 2012 Jul; 21(8):865-71. PubMed ID: 22399073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies.
    Prieto GA; Cabral AR; Zapata-Zuñiga M; Simón AJ; Villa AR; Alarcón-Segovia D; Cabiedes J
    Arthritis Rheum; 2003 Feb; 48(2):471-4. PubMed ID: 12571857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
    Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
    Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Val/Leu247 polymorphism of β2-glycoprotein I and thrombosis in Chinese patients with SLE.
    Liang W; Zhou J; Zhou S; Wang T; Yang L; Xu D; Deng G; Huang D; Mei C; He Y; Zhang Z
    Int J Lab Hematol; 2015 Feb; 37(1):22-8. PubMed ID: 24661363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
    Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
    Marie I; Jouen F; Hellot MF; Levesque H
    Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
    Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
    Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Val247Leu β2-glycoprotein-I allelic variant is associated with antiphospholipid syndrome: systematic review and meta-analysis.
    Chamorro AJ; Marcos M; Mirón-Canelo JA; Cervera R; Espinosa G
    Autoimmun Rev; 2012 Aug; 11(10):705-12. PubMed ID: 22246055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
    Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals.
    Palomo IG; Mujica VE; Alarcón ML; Pereira JG; Vásquez MR
    J Diabetes Complications; 2005; 19(3):133-7. PubMed ID: 15866057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.